Fingerprint
Dive into the research topics of 'Feasibility and dosimetry studies for 18F-NOS as a potential PET radiopharmaceutical for inducible nitric oxide synthase in humans'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Feasibility and dosimetry studies for 18F-NOS as a potential PET radiopharmaceutical for inducible nitric oxide synthase in humans
Pilar Herrero, Richard Laforest, Kooresh Shoghi, Dong Zhou, Gregory Ewald, John Pfeifer, Eric Duncavage, Kitty Krupp, Robert Mach, Robert J. Gropler
- Division of Radiological Sciences
- Institute of Clinical and Translational Sciences
- Siteman Cancer Center
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Division of Cardiology
- COVID-19 Researchers
- Precision Radio-Theranostics Translational Laboratories (PRT2L)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Division of Anatomic and Molecular Pathology (AMP)
- Department of Radiology
- DBBS - Molecular Cell Biology
- DBBS - Computational and Systems Biology
- DBBS - Biochemistry, Biophysics, and Structural Biology
Research output: Contribution to journal › Article › peer-review
27
Scopus
citations